Reozalimab Antibody
Reozalimab (LY3434172) is a PD-1/PD-L1 bispecific antibody that blocks this key immune checkpoint, promoting T-cell activation and demonstrating antitumor activity in vitro. It is a research tool for studying immuno-oncology mechanisms and therapeutic strategies in both cellular and animal models.
Product Specifications
Product Name Alternative
PDL1, PD-L1, LY3434172, LY 3434172, PD-1, PD1, PD1/PDL1
Target
PD-1/PD-L1
Clonality
Recombinant
Conjugation
Unconjugated
Field of Research
Cell Biology, Immunology & Inflammation
Concentration
5.72 mg/mL
Purity
95.00% (May vary between batches)
Molecular Weight
144.16 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC472398-500 1x 500 µL
SOX9 / SRY-box 9 (SOX9/2398), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 